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Abstract
Background: Schwannomas, also known as neurilemmomas, are benign slow-growing neoplasms originating from
a Schwann cell sheath. These neoplasms are rare among the mesenchymal tumors of the gastrointestinal tract. In
the stomach, Schwannomas only represent 0.2 % of all gastric tumors; this makes the presentation of a
schwannoma in the stomach of a man in his seventh decade unusual. This case report highlights the rarity of a
schwannoma at the greater curvature of the stomach because only a few cases have been reported in the
literature. This case describes the importance of including gastric schwannomas in the differential diagnosis when
preoperative assessment reveals a submucosal gastric mass with gastrointestinal stromal tumor as a leading
differential diagnosis because of its common occurrence at this site.
Case presentation: A 72-year-old man of Indian origin presented with a painless abdominal mass with nonspecific
gastrointestinal upset. An endoscopy showed a submucosal lesion in his stomach measuring 4×3×2 cm. Histology
revealed a benign spindle cell tumor. Immunohistochemistry confirmed the diagnosis of gastric schwannoma. He is
on regular follow-up and doing well.
Conclusions: It should be remembered that a schwannoma can present as a mass lesion in the stomach and
mimic gastrointestinal stromal tumor. Patients should undergo an endoscopy and a biopsy of the lesion should be
done. Many patients do not undergo endoscopy which can delay diagnosis and management. As these tumors
have an excellent prognosis, surgical removal is sufficient treatment. Surgeons, radiologists, pathologists and
gastroenterologists must be aware of this entity.
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Background
Schwannomas, also known as neurilemmomas, are
benign slow-growing neoplasms originating from a
Schwann cell sheath. These neoplasms are rare among
the mesenchymal tumors of the gastrointestinal tract but
develop most commonly in the stomach representing
0.2 % of all gastric tumors [1–6]. The main differential
diagnosis of a gastric submucosal schwannoma is a
gastrointestinal stromal tumor (GIST). However, treat-
ment and prognosis for gastric schwannomas and
GISTs vary because gastric schwannomas have an ex-
cellent prognosis because of their benign nature
whereas 10 to 30 % of GISTs can have malignant be-
havior with common recurrences. Malignant schwan-
nomas of the stomach are extremely rare. Hence, it is
important to make an accurate diagnosis for proper
treatment options as medical management is available
in the form of imatinib for GIST as compared to
schwannoma, as well as surgical intervention in both
[6, 7]. Patients can present with bleeding or a palpable
mass. Schwannomas present as submucosal tumors and
diagnosis is based on histological features and positivity
for S-100 and negativity for smooth muscle actin (SMA)
and c-Kit [3, 6–8]. As these tumors have an excellent
prognosis, surgical removal is sufficient treatment.
Case presentation
We present the case of a 72-year-old man of Indian ori-
gin who came to our hospital with complaints of a pain-
less mass with abdominal fullness. There was no
significant past medical, family, or psychosocial history.
There was no history of upper gastrointestinal bleed, or
past medical or surgical interventions. On physical
examination, he had mild pallor with ill-defined painless
swelling in his gastric region. There was no organome-
galy or lymphadenopathy. An upper gastrointestinal en-
doscopy was done which was suggestive of a submucosal
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lesion in his stomach. Our gastroenterologist thought of
GIST; leiomyoma and even gastric malignancy was also
suspected because of the patient’s old age. A subsequent
biopsy was taken which revealed only mucosal tissue. A
computed tomography (CT) scan of the patient’s abdo-
men showed an ovoid homogenous 4×3×2 cm mass at
the greater curvature of his stomach. There was no
other lesion in his whole body. We finally suspected sub-
mucosal tumor with the possibility of GIST. Considering
the large size of the tumor, location, difficulty of estab-
lishing a definite preoperative diagnosis in spite of inci-
sion biopsy, suspicion of malignant GIST/tumor, old age
and to prevent possible complications such as bleeding
or pyloric stenosis, surgical intervention was planned
and a subtotal gastrectomy was done. The surgical speci-
men was received in the department of pathology. On
gross examination, an intramural, nodular, solid mass
measuring 4×3×2 cm was seen. A cut section revealed
whorling trabeculation. Histological observations showed a
cellular tumor present in the submucosa, which extended
into his muscularis propria. The overlying mucosa was un-
remarkable. Sections from the tumor showed interlacing
bundles of spindle cells which had elongated nuclei, ill-
defined cytoplasmic borders and palisading nuclei. Mild
nuclear atypia was noted. These cells were separated by col-
lagenous strands. Mitotic activity 5/50 high-power fields
were seen; however, no necrosis/atypical mitosis were
identified (Fig. 1). There was no lymph node involve-
ment and the surgical margin was negative for tumor
cells. A histological diagnosis of a benign mesenchy-
mal tumor was made. Immunohistochemistry (IHC)
staining was strongly positive for vimentin and S-100
(Fig. 2a), whereas c-Kit (Fig. 2b), SMA and cytokera-
tin (CK) were negative. Hence, a final diagnosis of
schwannoma was made. His postoperative period was
uneventful and he was discharged in good condition.
Follow-up visits up to 1.5 years were unremarkable.
Discussion
The vast majority of spindle cell stromal tumors of the
gastrointestinal tract were once considered to originate
from smooth muscle. With the development of immu-
nohistochemical staining and electron microscopy vari-
ous distinct origins have become apparent. These have
allowed for a more precise classification among stromal
tumors of the gastrointestinal tract. The most common
gastrointestinal site is the stomach. Schwannomas con-
stitute 0.2 % of all gastric neoplasms [1]. Malignant
Fig. 1 a Tumor present in the submucosal region of the stomach (hematoxylin and eosin ×100). b Interlacing bundles of spindle cells had
elongated palisading nuclei with ill-defined cytoplasmic borders (hematoxylin and eosin ×200). c Close-up showing mild nuclear pleomorphism
with spindled-shaped nuclei and hypocellular regions (hematoxylin and eosin ×400)
Fig. 2 a Immunohistochemistry showed strong S-100 positivity. b Immunohistochemistry showed c-Kit negativity
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transformation of a gastric schwannoma is very rare.
These tumors arise from the fundus, body or antrum of
the stomach and are commonly intramural. Tumors can
vary from 0.5 to 11 cm in diameter. Schwannomas tend
to present in the fifth to sixth decades of life and more
commonly in females. They are usually asymptomatic
and can be discovered incidentally. They are usually soli-
tary lesions arising from the lesser curvature of the
stomach [2–4]; however, in our case it was the greater
curvature. The most common presenting symptom can
be upper gastrointestinal bleeding and abdominal dis-
comfort. On a CT scan, a gastric schwannoma tends to
be homogenous, which distinguishes it from leiomyomas
and leiomyosarcomas. Magnetic resonance imaging
(MRI) can determine the exact layer of origin and loca-
tion of the tumor [8]. The typical endoscopic appearance
of gastric schwannoma is a round protruding submuco-
sal mass with overlying ulcerated mucosa which is usu-
ally seen in patients with a history of gastrointestinal
bleeding. In our case, an initial biopsy revealed only mu-
cosal tissue; false-negative results of an endoscopic bi-
opsy can be given because normal mucosa overlies the
submucosal lesion. On pathological examination the tu-
mors are encased by intact mucosa and they principally
involve submucosa and muscularis propria. These tu-
mors have spindle-shaped nuclei and have a fascicular
arrangement. No mitosis/necrosis/significant nuclear
pleomorphism are seen. A diffuse and intense positivity
for vimentin and S-100 protein is detected. Gastric ma-
lignant schwannomas can be distinguished from benign
schwannomas on the basis of histological examination of
the resected specimens, not by clinical symptoms or im-
aging studies [3, 9–11]. The treatment options for gas-
tric schwannoma are the same regardless of whether the
tumor is benign or has malignant potential. Thus, surgi-
cal resection is the only possible treatment for gastric
schwannoma as compared to GIST where larger tumors
necessitate subtotal or total gastrectomy [12, 13].
Conclusions
It should be remembered that a schwannoma can
present as a mass lesion in the stomach and can mimic
GIST. Many patients do not undergo endoscopy which
can delay diagnosis and management. As these tumors
have an excellent prognosis, surgical removal in the form
of wedge resection, subtotal resection or near-total re-
section is sufficient treatment. The prognosis for pa-
tients with a solitary schwannoma of the stomach
following resection is very good. Surgeons, radiologists,
pathologists and gastroenterologists must be aware that
although gastric schwannomas are rare among spindle
cell tumors of the gastrointestinal tract, diagnosis should
always be confirmed by IHC and GISTs should be ruled
out. Although malignant transformation can occur, it is
very rare. Recurrent disease is generally associated with
an incomplete surgical margin. The use of molecular
therapy for gastric schwannoma is not clearly established
yet.
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